Dr. Igor Pagiola
INRAD - Instituto de Radiologia HCFMUSP
São Paulo, Brésil
IS MEVO THE NEW LVO?
Once again, we are at the stage where trials and clinical experience in the endovascular treatment of the acute phase of stroke are about to break paradigms [...].
Following the revolutionary impact of thrombectomy in 2015, could MeVo be the new LVO? Unveil the answer in this exclusive special report, where expert analysis, literature data, and key insights come together to answer this burning question for the future of neurointervention!
Join Prof. Mayank Goyal as he discusses a wide range of topics including: primary and secondary MEVO definition, efficacy of thrombolytic drugs, accessibility of medium vessel occlusions and ways to improve detection.
Discover the tips and tricks of Prof. René Chapot for performing thrombectomy in medium vessel occlusions. What are the criteria for an indication of MEVO treatment? Should stent retriever or aspiration be preferred ? How to manage bleeding situations?
There are many issues to consider in the treatment of MEVOs and additional data is needed to optimize the management of these cases. Dive into this exploration of devices and techniques. How should the ideal device be? Find out Dr. Thomas Yasuda's answer.
Watch this interview featuring Prof. Markus A. Möhlenbruch who shares several occlusion cases, evokes the Sylvian point as well as the problem of M2/M3 straightening.
Based on the latest published results of trials, Dr. Fouzi Bala offers here a global review of the literature on acute ischemic stroke due to medium vessel occlusion.